ELF3 is an antagonist of oncogenic-signalling-induced expression of EMT-TF ZEB1

MLA

R Harris, et al. “ELF3 Is an Antagonist of Oncogenic-Signalling-Induced Expression of EMT-TF ZEB1.” Cancer Biology & Therapy, vol. 20, Aug. 2018, pp. 90–100. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....dcadac13180ba1202efca83a51801121&authtype=sso&custid=ns315887.

APA

R Harris, Xianglin Yuan, S Bai, Emily H Bowler, M Ravasz, Zhenghe Wang, Y Skomorovska, Dian Liu, Mehmet Koyutürk, K Tamai, Marzieh Ayati, Jing Song, Rob M. Ewing, & Yihua Wang. (2018). ELF3 is an antagonist of oncogenic-signalling-induced expression of EMT-TF ZEB1. Cancer Biology & Therapy, 20, 90–100.

Chicago

R Harris, Xianglin Yuan, S Bai, Emily H Bowler, M Ravasz, Zhenghe Wang, Y Skomorovska, et al. 2018. “ELF3 Is an Antagonist of Oncogenic-Signalling-Induced Expression of EMT-TF ZEB1.” Cancer Biology & Therapy 20 (August): 90–100. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....dcadac13180ba1202efca83a51801121&authtype=sso&custid=ns315887.